TREATMENT FAQs

COMMON QUESTIONS ABOUT MAVYRET

Even if you don't have symptoms of hep C, there’s no reason to wait to talk to your healthcare professional about treatment. Start by getting answers to some basic questions you may have about MAVYRET.

Questions about Coronavirus

About MAVYRET

The hep C virus can make about a trillion copies per day. MAVYRET is a combination of 2 medications, glecaprevir and pibrentasvir, that work together to help stop the hep C virus from multiplying.

Learn more about how MAVYRET works to cure* all types of hep C.

*Cure means no hep C virus found in the blood 3 months after treatment ends. Individual results may vary.

MAVYRET can cause serious side effects, including:
Hepatitis B virus (hep B) reactivation.
Before starting treatment with MAVYRET, your healthcare professional will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your healthcare professional will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. For more information about side effects, see the section “What are the possible side effects of MAVYRET?”

"Cured" means that no hep C virus can be found in your blood 3 months after you finish your hep C treatment with MAVYRET. Individual results may vary.

What to know before starting treatment with MAVYRET

What to know while taking MAVYRET